Pre-Deployment Robustness Stress Testing for CT Segmentation Systems Using Clinically Motivated Multi-Corruption Augmentation

Researchers introduce RAMP, a robustness-oriented augmentation framework that improves CT segmentation systems' performance under real-world clinical imaging degradation. The method reduces the clean-to-corrupted performance gap by up to 76% while maintaining strong segmentation accuracy on corrupted medical images, advancing AI reliability in clinical deployment.

This research addresses a critical gap between laboratory performance and real-world clinical deployment of deep learning medical imaging systems. While CT segmentation models achieve high accuracy on clean benchmark datasets, their performance degrades significantly when encountering the noise, artifacts, and quality variations inherent in actual clinical workflows. RAMP tackles this reliability challenge through clinically motivated multi-corruption augmentation that exposes models to plausible image degradations during training, bridging the accuracy-robustness tradeoff.

The approach builds on growing recognition within medical AI that benchmark performance metrics poorly predict clinical utility. Previous segmentation frameworks like nnU-Net achieved strong clean-image accuracy but exhibited substantial robustness gaps—a dangerous liability in healthcare where model failures can directly impact patient outcomes. RAMP's anatomically constrained perturbations and stochastic corruption composition represent a sophisticated refinement that maintains anatomical validity while introducing realistic degradation scenarios.

For medical device developers and healthcare IT decision-makers, RAMP provides a practical pre-deployment validation methodology that could reduce costly clinical integration failures. The framework's ability to reduce robustness gaps from 0.26-0.29 to 0.06-0.07 demonstrates substantial improvement in worst-case performance—precisely the metric that determines clinical trustworthiness. This work exemplifies how augmentation strategies can serve as risk mitigation tools rather than mere performance optimizers, directly addressing deployment barriers in regulated medical environments.

Future clinical AI development should integrate similar robustness testing frameworks as standard pre-deployment validation. The methodology's success across multiple segmentation benchmarks suggests broader applicability to other medical imaging tasks and potentially non-medical computer vision systems operating in variable real-world conditions.

• →RAMP reduced clean-to-corrupted robustness gap by 76% on five-organ benchmark and 76% on Abdomen1K dataset compared to baseline nnU-Net
• →Multi-corruption augmentation improves worst-case segmentation performance under severe image degradation, critical for reliable clinical deployment
• →Framework combines anatomically constrained spatial perturbations with CT-specific intensity transformations and stochastic corruption composition
• →Mean corrupted Dice scores improved from 0.610 to 0.753 on noisy benchmark, demonstrating substantial robustness gains
• →Approach provides practical pre-deployment validation strategy addressing the accuracy-robustness tradeoff in medical imaging AI systems